Skip to main content
CLOV
NASDAQ Life Sciences

Clover Health Targets GAAP Profitability by 2026, Signaling Stronger Financial Outlook

Tom Rudovsky · Reported by Wiseek News
More coverage: Financial
Sentiment info
Positive
Importance info
8
Price
$2
Mkt Cap
$1.044B
52W Low
$1.92
52W High
$3.92
52W Position info
4.2% above low
Off High info
49% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CLOV is trading near its 52-week low of $1.92 (4.2% above the low).

Summary

Clover Health has announced a new target to achieve GAAP profitability by 2026. This represents a significant upgrade from prior guidance, which focused on achieving positive Adjusted EBITDA in 2026, as detailed in the company's 8-K and 8-K/A filings on February 26 and March 6. While the headline also mentions a partnership with Kno2, that specific news was already reported earlier today. The explicit goal of GAAP profitability is a material positive development for Clover Health, particularly given its recent financial performance, including substantial net losses and negative operating cash flow in 2025. This new target provides a clearer and more ambitious path to sustainable financial health, which could significantly improve investor confidence for a company currently trading near its 52-week low. Traders will be watching for further updates on the company's progress towards this critical financial milestone.

At the time of this announcement, CLOV was trading at $2.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $1.92 to $3.92. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CLOV - Latest Insights

CLOV
Nov 06, 2026, 8:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.45
Real-time Price: $3.70 info
Change: -$0.7502 (-17%) info
Market Cap: $2.002B info
CLOV
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.67
Real-time Price: $3.70 info
Change: -$0.970 (-21%) info
Market Cap: $2.002B info
CLOV
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $4.71
Real-time Price: $3.70 info
Change: -$1.01 (-21%) info
Market Cap: $2.002B info
CLOV
Oct 08, 2026, 6:45 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $3.70 info
Change: -$1.30 (-26%) info
Market Cap: $2.002B info
CLOV
Aug 07, 2026, 8:04 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.69
Real-time Price: $3.70 info
Change: -$0.990 (-21%) info
Market Cap: $2.002B info